The Global Stem Cells Group has announced the addition of Biomedical Researcher Mario Camacho Alcocer to its faculty. has recruited Mario Camacho Alcocer to the company’s growing faculty. Camacho Alcocer, a biomedical researcher and founding partner of Criogenix SA de CV in Queretaro, Mexico, will join GSCG’s team of biomedical professors who will teach the “Diplomat in Cell Therapy and Tissue Engineering” program.
Criogenix SA de CV is a private company registered in the National Record of Scientific and Technological Institutions and Companies in Mexico (RENIECYT).
Camacho Alcocer will teach two-day, interactive training courses on adult stem cell extraction and re-integration to physicians and qualified medical practitioners who wish to learn and use the process in their practices.
Camacho Alcocer is accomplished in generating and applying new stem cell therapeutic protocols and technologies. His current research focuses on extracellular matrix interactions to regulate the dynamic of defined stem cells populations, with a goal to regenerate functional capabilities of specific tissues (or to develop tissues in vitro), as well as the development of specific scaffolds for cell culture. His research is central to Criogenix SA de CV’s development of a major integral stem cell unit management system for therapeutic applications.
Global Stem Cells Group and StemCell Center are expanding the company’s clinical presence worldwide by partnering with experienced and qualified regenerative medicine physicians to open new clinics licensed and developed under the Cellgenic banner.
In 2014, Global Stem Cells Group expanded its StemCell Center’s global presence to 20 countries. Cellgenic offers stem cell treatments to help treat a variety of diseases and conditions including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, and pain due to injuries at various facilities worldwide.
Cellgenic is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. Cellgenic clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.
The Global Stem Cells Group is committed to the highest standards in service and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.

Previous Post
Global Stem Cells Group, Inc. Announces Launch of New Stem Cell Harvesting Products
Next Post
Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China

Latest posts